tci Medicare Compliance & Reimbursement - 2003 Issue 32

FEDS SEEK INFO ON BRISTOL-MYERS COMPLIANCE REVIEW

Internal review covers sales, marketing and pricing practices.As government scrutiny builds on pharma companies' sales and marketing practices, drugmakers are facing investigations from every quarter: the Department of Justice, state attorneys general, the HHS Office of Inspector General and even Congress. In the latest development, New York-based Bristol-Myers Squibb Co. says the U.S. attorney's office in Massachusetts - a particularly aggressive office when it comes to health care fraud enforcement - wants the results of an internal compliance review the company is conducting of its sales and marketing practices. In an Aug. 8 filing with the Securities...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.